322 related articles for article (PubMed ID: 12447371)
1. The mismatch repair system is required for S-phase checkpoint activation.
Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R
Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371
[TBL] [Abstract][Full Text] [Related]
2. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
3. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
4. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.
Yazdi PT; Wang Y; Zhao S; Patel N; Lee EY; Qin J
Genes Dev; 2002 Mar; 16(5):571-82. PubMed ID: 11877377
[TBL] [Abstract][Full Text] [Related]
5. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
[TBL] [Abstract][Full Text] [Related]
6. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS
Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053
[TBL] [Abstract][Full Text] [Related]
7. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.
Falck J; Petrini JH; Williams BR; Lukas J; Bartek J
Nat Genet; 2002 Mar; 30(3):290-4. PubMed ID: 11850621
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
[TBL] [Abstract][Full Text] [Related]
10. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
Jin J; Ang XL; Ye X; Livingstone M; Harper JW
J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
[TBL] [Abstract][Full Text] [Related]
11. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest.
Girard PM; Riballo E; Begg AC; Waugh A; Jeggo PA
Oncogene; 2002 Jun; 21(27):4191-9. PubMed ID: 12082606
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
13. Chk2 activation dependence on Nbs1 after DNA damage.
Buscemi G; Savio C; Zannini L; Miccichè F; Masnada D; Nakanishi M; Tauchi H; Komatsu K; Mizutani S; Khanna K; Chen P; Concannon P; Chessa L; Delia D
Mol Cell Biol; 2001 Aug; 21(15):5214-22. PubMed ID: 11438675
[TBL] [Abstract][Full Text] [Related]
14. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
[TBL] [Abstract][Full Text] [Related]
15. Repair affairs.
Nat Genet; 2000 Apr; 24(4):325-6. PubMed ID: 10742084
[No Abstract] [Full Text] [Related]
16. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Lim DS; Kim ST; Xu B; Maser RS; Lin J; Petrini JH; Kastan MB
Nature; 2000 Apr; 404(6778):613-7. PubMed ID: 10766245
[TBL] [Abstract][Full Text] [Related]
17. MDC1 is required for the intra-S-phase DNA damage checkpoint.
Goldberg M; Stucki M; Falck J; D'Amours D; Rahman D; Pappin D; Bartek J; Jackson SP
Nature; 2003 Feb; 421(6926):952-6. PubMed ID: 12607003
[TBL] [Abstract][Full Text] [Related]
18. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
19. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
[TBL] [Abstract][Full Text] [Related]
20. Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.
Zhang X; Succi J; Feng Z; Prithivirajsingh S; Story MD; Legerski RJ
Mol Cell Biol; 2004 Oct; 24(20):9207-20. PubMed ID: 15456891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
